Valion Bio, Inc. Depreciation
Valion Bio, Inc. (VBIO) reported Depreciation of $358.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-14
- Valion Bio, Inc. depreciation for the quarter ending 2026-06-30 was $358.00K, a 35700.00% increase year-over-year.
- Valion Bio, Inc. depreciation for the quarter ending 2026-03-31 was $4.00K, a 300.00% increase year-over-year.
- Valion Bio, Inc. depreciation for the quarter ending 2025-12-31 was $3.00K.
- Valion Bio, Inc. depreciation for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Valion Bio, Inc. depreciation for fiscal 2025 was $5.00K, a 66.67% increase from fiscal 2024.
- Valion Bio, Inc. depreciation for fiscal 2024 was $3.00K, a 62.50% decline from fiscal 2023.
- Valion Bio, Inc. depreciation for fiscal 2023 was $8.00K, a 20.00% decline from fiscal 2022.
- Valion Bio, Inc. depreciation for fiscal 2022 was $10.00K, a 25.00% increase from fiscal 2021.
| Period end | Depreciation 1 month | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $358.00K 10-Q · filed 2026-08-14 | $362.00K 10-Q · filed 2026-08-14 | $365.00K derived: sum of 3 quarters · filed 2026-08-14 | $365.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $4.00K 10-Q · filed 2026-05-14 | $7.00K derived: sum of 2 quarters · filed 2026-05-14 | $7.00K derived: sum of 3 quarters · filed 2026-05-14 | $8.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $3.00K derived: sum of 2 quarters · filed 2026-03-30 | $4.00K derived: sum of 3 quarters · filed 2026-08-14 | $5.00K 10-K · filed 2026-03-30 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | $1.00K derived: sum of 2 quarters · filed 2026-08-14 | $2.00K 10-Q · filed 2025-11-14 | $2.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $1.00K 10-Q · filed 2026-08-14 | $2.00K 10-Q · filed 2026-08-14 | $2.00K derived: sum of 3 quarters · filed 2026-08-14 | $3.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $1.00K 10-Q · filed 2026-05-14 | $1.00K derived: sum of 2 quarters · filed 2026-05-14 | $2.00K derived: sum of 3 quarters · filed 2026-05-14 | $3.00K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.00K derived: sum of 2 quarters · filed 2026-03-30 | $2.00K derived: sum of 3 quarters · filed 2026-03-30 | $3.00K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $1.00K 10-Q · filed 2025-11-14 | $2.00K derived: sum of 2 quarters · filed 2025-11-14 | $3.00K 10-Q · filed 2025-11-14 | $5.00K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $2.00K 10-Q · filed 2025-08-14 | $4.00K derived: sum of 3 quarters · filed 2025-08-14 | $4.00K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $1.00K 10-Q · filed 2025-05-15 | $3.00K derived: sum of 2 quarters · filed 2025-05-15 | $3.00K derived: sum of 3 quarters · filed 2025-05-15 | $7.00K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $2.00K derived: sum of 2 quarters · filed 2025-03-21 | $6.00K derived: sum of 3 quarters · filed 2025-03-21 | $8.00K 10-K · filed 2025-03-21 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $4.00K derived: sum of 2 quarters · filed 2024-11-14 | $6.00K 10-Q · filed 2024-11-14 | $9.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $6.00K 10-Q · filed 2024-08-14 | $9.00K derived: sum of 3 quarters · filed 2024-08-14 | $12.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $2.00K 10-Q · filed 2024-05-15 | $5.00K derived: sum of 2 quarters · filed 2024-05-15 | $8.00K derived: sum of 3 quarters · filed 2024-05-15 | $10.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $6.00K derived: sum of 2 quarters · filed 2024-03-25 | $8.00K derived: sum of 3 quarters · filed 2024-03-25 | $10.00K 10-K · filed 2024-03-25 | |
| 2022-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $5.00K derived: sum of 2 quarters · filed 2023-11-14 | $7.00K 10-Q · filed 2023-11-14 | $9.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $4.00K 10-Q · filed 2023-08-14 | $6.00K derived: sum of 3 quarters · filed 2023-08-14 | $8.00K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $2.00K 10-Q · filed 2023-05-15 | $4.00K derived: sum of 2 quarters · filed 2023-05-15 | $6.00K derived: sum of 3 quarters · filed 2023-05-15 | $8.00K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2022-01-31 | $2.00K 10-Q · filed 2022-05-16 | ||||
| 2021-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $4.00K derived: sum of 2 quarters · filed 2023-03-31 | $6.00K derived: sum of 3 quarters · filed 2023-03-31 | $8.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $4.00K derived: sum of 2 quarters · filed 2022-11-14 | $6.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $4.00K 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |